The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Update on Familial Pancreatic Cancer
Open accessAbstract
It has been suggested that ~10% of pancreatic cancer has a familial basis 1, 2. Individuals with a family history of pancreatic cancer have an increased risk of developing both pancreatic and extrapancreatic malignancies, and an individual’s risk of developing pancreatic cancer can now be quantified based on their family cancer history 1, 3, 4. While some of the aggregation of pancreatic cancer in families is due to chance, and some to shared environmental exposures such as cigarette smoking, it is now clear that much of this aggregation has a genetic basis 5. Several of the genes responsible for the familial clustering of pancreatic cancer have been discovered. For example, germline mutations in the BRCA2 gene cause familial breast cancer, and individuals with germline BRCA2 gene mutations have an approximately 3.5-fold increased risk of pancreatic cancer 6–12. Germline mutations in the p16/CDKN2A gene cause the Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome, and these individuals have a 13 to 37-fold increased risk of pancreatic cancer 10, 13–23. Inherited mutations in the STK11 gene cause the Peutz-Jeghers syndrome, and individuals with Peutz-Jeghers have a 130-fold increased risk of pancreatic cancer 24–30. The discovery of these familial pancreatic cancer genes has helped identify cellular pathways important for the development of pancreatic cancer, it has provided a basis for genetic counseling of individuals with a family history of pancreatic cancer, and it has established a foundation for prioritizing patients for screening for early pre-invasive disease 21, 29, 31–33. In addition, the discovery of familial pancreatic cancer genes has also lead to the development of gene-specific therapies as demonstrated by the remarkable sensitivity of pancreatic cancers harboring mutations in the BRCA2 gene to Poly[ADP-ribose] polymerase (PARP) inhibitors and to mitomycin C 34–41. The field of familial pancreatic cancer is getting even more exciting as we enter the era of whole genome sequencing. For example, this year the PALB2 gene was discovered to be a familial pancreatic cancer susceptibility gene through complete, unbiased, sequencing of all of the protein-coding genes in a single patient’s cancer 42, 43. As the speed of “next generation” sequencing technologies rises and the costs fall, we can foresee the discovery of a number of new familial pancreatic cancer genes in the coming years. The known genetic syndromes account for less than 20% of the observed familial aggregation of pancreatic cancer, and the discovery of additional familial pancreatic cancer genes remains one of the most exciting opportunities in pancreatic cancer research 1, 2. As these genes are discovered, the challenge will be to use these scientific breakthroughs to improve clinical care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 1×
“Germline BRCA1 gene mutations have been reported in only a few patients with familial pancreatic cancer [69–72].”
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,757
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
Whitcomb, D. C., Gorry, M. C., Preston, R. A., Furey, W., Sossenheimer, M. J., Ulrich, C. D., Martin, S. P., Gates, L. K., Amann, S. T., Toskes, P. P., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-141 · Cited by 1,628
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Very high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,445
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Lynch, H. T., Smyrk, T. C., Watson, P., Lanspa, S. J., Lynch, J. F., Lynch, P. M., Cavalieri, R. J., & Boland, C. R. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90368-m · Cited by 1,065
Witt, H., Luck, W., Hennies, H. C., Claßen, M., Kage, A., Laß, U., Landt, O., & Becker, M. (2000) · Nature Genetics · doi:10.1038/76088 · Cited by 1,034
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
Increased Risk of Cancer in the Peutz–Jeghers Syndrome
Giardiello, F. M., Welsh, S. B., Hamilton, S. R., Offerhaus, G. J. A., Gittelsohn, A. M., Booker, S. V., Krush, A. J., Yardley, J. H., & Luk, G. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162404 · Cited by 848
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 5×
“the protein-coding genes in a single patient’s cancer [42,43].”
InfluentialSelf-citationDonawho, C. K., Luo, Y., Luo, Y., Penning, T. D., Bauch, J. L., Bouska, J. J., Bontcheva-Diaz, V. D., Cox, B. F., DeWeese, T. L., Dillehay, L. E., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3039 · Cited by 773
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3823 · Cited by 678
Self-citationGermline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins, M., Schutte, M. E. M., Lü, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., et al. (1996) · PubMed · Cited by 642
Self-citationIncreased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Jeghers, H., McKusick, V. A., & Katz, K. H. (1949) · New England Journal of Medicine · doi:10.1056/nejm194912222412501 · Cited by 571
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 562
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study
Canto, M. I., Goggins, M., Hruban, R. H., Petersen, G. M., Giardiello, F. M., Yeo, C., Fishman, E. K., Brune, K., Axilbund, J., Griffin, C., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.005 · Cited by 524
Self-citationBRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
Gorry, M., Gabbaizedeh, D., Furey, W., Gates, L., Preston, R., Aston, C., Zhang, Y., Ulrich, C., Ehrlich, G., & Whitcomb, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322498 · Cited by 478
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
Canto, M. I., Goggins, M., Yeo, C. J., Griffin, C., Axilbund, J. E., Brune, K., Ali, S. Z., Jagannath, S., Petersen, G. M., Fishman, E. K., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00244-7 · Cited by 448
Self-citationMurphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435
Self-citationGoldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M.-F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0494 · Cited by 426
Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome
Boardman, L. A., Thibodeau, S. N., Schaid, D. J., Lindor, N. M., McDonnell, S. K., Burgart, L. J., Ahlquist, D. A., Podratz, K. C., Pittelkow, M., & Hartmann, L. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00004 · Cited by 421
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary
van Asperen, C. J., Brohet, R. M., Meijers-Heijboer, E. J., Hoogerbrugge, N., Verhoef, S., Vasen, H. F. A., Ausems, M. G. E. M., Menko, F. H., Gomez Garcia, E. B., Klijn, J. G. M., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028829 · Cited by 420
Su, G. H., Hruban, R. H., Bansal, R. K., Bova, G. S., Tang, D. J., Shekher, M. C., Westerman, A. M., Entius, M. M., Goggins, M., Yeo, C. J., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65440-5 · Cited by 417
Self-citationCancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Silverman, D. T., Schiffman, M., Everhart, J., Goldstein, A., Lillemoe, K. D., Swanson, G. M., Schwartz, A. G., Brown, L. M., Greenberg, R. S., Schoenberg, J. B., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690607 · Cited by 397
Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., & Kimmey, M. B. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00003 · Cited by 391 · cited 2×
“cancer [108,112].”
Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-188 · Cited by 381
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.
Giardiello, F. M., Offerhaus, G. J., Lee, D. H., Krush, A. J., Tersmette, A. C., Booker, S. V., Kelley, N. C., & Hamilton, S. R. (1993) · Gut · doi:10.1136/gut.34.10.1394 · Cited by 363
(2006) · PubMed · Cited by 347
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Borg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Risk Factors for Pancreatic Cancer: Case-Control Study
Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J.-N., Pisters, P. W., Evans, D. B., Khan, R., Chou, T.-H., Lenzi, R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01510.x · Cited by 331
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-126 · Cited by 304
LIFE-STYLE RISK FACTORS FOR PANCREATIC CANCER IN LOUISIANA: A CASE-CONTROL STUDY
FALK, R. T., WILLIAMS PICKLE, L., FONTHAM, E. T., CORREA, P., & FRAUMENI, J. F. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114972 · Cited by 300
Predictors of pancreatic cancer mortality among a large cohort of United States adults
Coughlin, S. S., Calle, E. E., Patel, A. V., & Thun, M. J. (2000) · Cancer Causes & Control · doi:10.1023/a:1026580131793 · Cited by 275
The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Brune, K., de Andrade, M., Goggins, M., Rothenmund, H., Gallinger, S., Klein, A., Petersen, G. M., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0783 · Cited by 275
Self-citationCancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family
Amundadottir, L. T., Thorvaldsson, S., Gudbjartsson, D. F., Sulem, P., Kristjansson, K., Arnason, S., Gulcher, J. R., Bjornsson, J., Kong, A., Thorsteinsdottir, U., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010065 · Cited by 270
Sato, N., Rosty, C., Jansen, M., Fukushima, N., Ueki, T., Yeo, C. J., Cameron, J. L., Iacobuzio-Donahue, C. A., Hruban, R. H., & Goggins, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63053-2 · Cited by 267
Self-citationFanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 264
Self-citationPoley, J. W., Kluijt, I., Gouma, D. J., Harinck, F., Wagner, A., Aalfs, C., van Eijck, C. H. J., Cats, A., Kuipers, E. J., Nio, Y., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.276 · Cited by 257
Hereditary Nonpolyposis Colorectal Cancer—Lynch Syndromes I and II
Lynch, H. T., Lampa, S. J., Boman, B. M., Smyrk, T., Watson, P., Lynch, J. F., Lynch, P. M., Cristofaro, G., Bufo, P., Tauro, A. V., et al. (1988) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00399-x · Cited by 254
Langer, P., Kann, P. H., Fendrich, V, Habbe, N., Schneider, M., Sina, M., Slater, E. P., Heverhagen, J. T., Gress, T. M., Rothmund, M., et al. (2009) · Gut · doi:10.1136/gut.2008.171611 · Cited by 249
Permuth-Wey, J., & Egan, K. M. (2009) · Familial Cancer · doi:10.1007/s10689-008-9214-8 · Cited by 232
Lal, G., Liu, G., Schmocker, B., Kaurah, P., Özçelik, H., Narod, S. A., Redston, M. S., & Gallinger, S. (2000) · PubMed · Cited by 231
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
Özcelik, H., Schmocker, B., Nicola, N. D., Shi, X.-H., Langer, B., Moore, M., Taylor, B. R., Narod, S. A., Darlington, G., Andrulis, I. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-17 · Cited by 225
Lynch, H. T., Brand, R. E., Hogg, D., Deters, C. A., Fusaro, R. M., Lynch, J. F., Liu, L., Knezetic, J., Lassam, N. J., Goggins, M., et al. (2002) · Cancer · doi:10.1002/cncr.10159 · Cited by 222
Self-citationPancPRO: Risk Assessment for Individuals With a Family History of Pancreatic Cancer
Wang, W., Chen, S., Brune, K. A., Hruban, R. H., Parmigiani, G., & Klein, A. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2452 · Cited by 219
Self-citationThe lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan, J. M., Offit, K., Foulkes, W. D., Robson, M. E., Wacholder, S., Eng, C. M., Karp, S. E., & Begg, C. B. (2001) · PubMed · Cited by 218
Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism
Pogue-Geile, K. L., Chen, R., Bronner, M. P., Crnogorac-Jurcevic, T., Moyes, K. W., Dowen, S., Otey, C. A., Crispin, D. A., George, R. D., Whitcomb, D. C., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030516 · Cited by 215
Shi, C., Hruban, R. H., & Klein, A. P. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.365 · Cited by 212
Self-citationDouble-Strand Break Repair Deficiency and Radiation Sensitivity in BRCA2 Mutant Cancer Cells
Abbott, D. W., Holt, J. T., & Freeman, M. L. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.978 · Cited by 206
Family history and the risk of liver, gallbladder, and pancreatic cancer.
Fernández, E., Vecchia, C. L., D’Avanzo, B., Negri, E., & Franceschi, S. (1994) · PubMed · Cited by 200
Quality-of-Life After Total Pancreatectomy: Is It Really That Bad on Long-term Follow-up?
Billings, B. J., Christein, J. D., Harmsen, W. S., Harrington, J. R., Chari, S. T., Que, F. G., Farnell, M. B., Nagorney, D. M., & Sarr, M. G. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.05.014 · Cited by 196
Ghadirian, P., Boyle, P., Simard, A., Baillargeon, J., Maisonneuve, P., & Perret, C. (1991) · International journal of pancreatology · doi:10.1007/bf02924156 · Cited by 193
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: A family study
Lynch, H. T., Voorhees, G. J., Lanspa, S. J., McGreevy, P. S., & Lynch, J. F. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.187 · Cited by 192
Tischkowitz, M. D., Sabbaghian, N., Hamel, N., Borgida, A., Rosner, C., Taherian, N., Srivastava, A., Holter, S., Rothenmund, H., Ghadirian, P., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.055 · Cited by 189
CDKN2A Germline Mutations in Familial Pancreatic Cancer
Bartsch, D. K., Sina-Frey, M., Lang, S., Wild, A., Gerdes, B., Barth, P., Kress, R., Grützmann, R., Colombo-Benkmann, M., Ziegler, A., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200212000-00005 · Cited by 186
Poly(ADP-ribose) Polymerase (PARP-1) in Homologous Recombination and as a Target for Cancer Therapy
Helleday, T., Bryant, H. E., & Schultz, N. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2031 · Cited by 184
Sugiyama, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00760-6 · Cited by 183
de Snoo, F. A., Bishop, D. T., Bergman, W., van Leeuwen, I., van der Drift, C., van Nieuwpoort, F. A., Out-Luiting, C. J., Vasen, H. F., ter Huurne, J. A. C., Frants, R. R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0403 · Cited by 181
The Role of Total Pancreatectomy and Islet Autotransplantation for Chronic Pancreatitis
Blondet, J. J., Carlson, A. M., Kobayashi, T., Jie, T., Bellin, M., Hering, B. J., Freeman, M. L., Beilman, G. J., & Sutherland, D. E. R. (2007) · Surgical Clinics of North America · doi:10.1016/j.suc.2007.08.014 · Cited by 174
Schneider, A. T., Suman, A., Rossi, L., Barmada, M. M., Beglinger, C., Parvin, S., Sattar, S., Ali, L., Khan, A. K. A., Gyr, N. E., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36059 · Cited by 155
In vivoTherapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor
van der Heijden, M. S., Brody, J. R., Dezentjé, D. A., Gallmeier, E., Cunningham, S. C., Swartz, M. J., Marzo, A. M. D., Offerhaus, G. J. A., Isacoff, W. H., Hruban, R. H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1048 · Cited by 150
Self-citationMcCabe, N., Lord, C. J., Tutt, A. N. J., Martin, N. M. B., Smith, G. C. M., & Ashworth, A. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.9.2141 · Cited by 148
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Boardman, L., McWilliams, R. R., de Andrade, M., & Petersen, G. M. (2005) · Cancer Research · doi:10.1158/0008-5472.383.65.2 · Cited by 146
Evidence for a major gene influencing risk of pancreatic cancer
Klein, A. P., Beaty, T. H., Wilson, J., Brune, K. A., Hruban, R. H., & Petersen, G. M. (2002) · Genetic Epidemiology · doi:10.1002/gepi.1102 · Cited by 142
Self-citationAntoniou, A. C., Pharoah, P. D. P., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Olsson, H. L., Johannsson, O. T., Borg, Å., Pasini, B., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024133 · Cited by 141
Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds
Rulyak, S. J., Kimmey, M. B., Veenstra, D. L., & Brentnall, T. A. (2003) · Gastrointestinal Endoscopy · doi:10.1067/mge.2003.28 · Cited by 134
Familial and second primary pancreatic cancers: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2002) · International Journal of Cancer · doi:10.1002/ijc.10863 · Cited by 126
Pancreatic Cancer and the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome
Lynch, H. T., & Fusaro, R. M. (1991) · Pancreas · doi:10.1097/00006676-199103000-00001 · Cited by 110
Gruis, N. A., Sandkuijl, L. A., van der Velden, P. A., Bergman, W., & Frants, R. R. (1995) · Melanoma Research · doi:10.1097/00008390-199506000-00005 · Cited by 110
Diabetic control after total pancreatectomy
Jethwa, P., Sodergren, M. H., Lala, A., Webber, J., Buckels, J. A. C., Bramhall, S. R., & Mirza, D. F. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.01.022 · Cited by 106
The effect of a single BRCA2 mutation on cancer in Iceland
Tulinius, H., Ólafsdóttir, G. H., Sigvaldason, H., Arason, A., Barkardottir, R. B., Egilsson, V., Ogmundsdottir, H. M., Tryggvadóttír, L., Gudlaugsdottir, S., & Eyfjord, J. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.7.457 · Cited by 89
Risk of malignancy in first‐degree relatives of patients with pancreatic carcinoma
McWilliams, R. R., Rabe, K. G., Olswold, C., de Andrade, M., & Petersen, G. M. (2005) · Cancer · doi:10.1002/cncr.21166 · Cited by 83
Peutz–Jeghers syndrome and screening for pancreatic cancer
Latchford, A. R., Greenhalf, W., Vitone, L. J., Neoptolemos, J. P., Lancaster, G., & Phillips, R. K. S. (2006) · British journal of surgery · doi:10.1002/bjs.5609 · Cited by 72
Elevated Cancer Mortality in the Relatives of Patients with Pancreatic Cancer
Wang, L., Brune, K. A., Visvanathan, K., Laheru, D. A., Herman, J. M., Wolfgang, C. L., Schulick, R. D., Cameron, J. L., Goggins, M., Hruban, R. H., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0557 · Cited by 68
Self-citationGermline BRCA1 mutations predispose to pancreatic adenocarcinoma
Al-Sukhni, W., Rothenmund, H., Borgida, A., Zogopoulos, G., O’Shea, A.-M., Pollett, A. F., & Gallinger, S. (2008) · Human Genetics · doi:10.1007/s00439-008-0554-0 · Cited by 67
Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European Families
Slater, E. P., Amrillaeva, V., Fendrich, V., Bartsch, D. K., Earl, J., Vitone, L. J., Neoptolemos, J. P., & Greenhalf, W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040164 · Cited by 64
Salaria, S. N., Illei, P. B., Sharma, R. B., Walter, K., Klein, A. P., Eshleman, J. R., Maitra, A., Schulick, R. D., Winter, J. M., Ouellette, M. M., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.3.3904 · Cited by 61
Self-citationHay, T., Jenkins, H., Sansom, O. J., Martin, N. M. B., Smith, G. C. M., & Clarke, A. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1186 · Cited by 59
Absence of germline BRCA1 mutations in familial pancreatic cancer patients
Axilbund, J. E., Argani, P., Kamiyama, M., Palmisano, E., Raben, M., Borges, M. W., Brune, K. A., Goggins, M., Hruban, R. H., & Klein, A. P. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.2.7136 · Cited by 58
Self-citationFiger, A., Irmin, L., Geva, R., Flex, D., Sulkes, J., Sulkes, A., & Friedman, E. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1605 · Cited by 57
Carcinoma In Situ of the Pancreas Associated with Localized Fibrosis
Takaori, K., Matsusue, S., Fujikawa, T., Kobashi, Y., Ito, T., Matsuo, Y., OISHI, H., & Takeda, H. (1998) · Pancreas · doi:10.1097/00006676-199807000-00015 · Cited by 53
Evaluation of the 4q32-34 Locus in European Familial Pancreatic Cancer
Earl, J., Yan, L., Vitone, L. J., Risk, J. M., Kemp, S. J., McFaul, C., Neoptolemos, J. P., Greenhalf, W., for the European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer, Kress, R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0376 · Cited by 50
Zogopoulos, G., Rothenmund, H., Eppel, A., Ash, C., Akbari, M. R., Hedley, D. W., Narod, S. A., & Gallinger, S. (2007) · Human Genetics · doi:10.1007/s00439-007-0361-z · Cited by 48
James, E. S., Waldron-Lynch, M., & Saif, M. W. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832b511e · Cited by 46
Absence of Deleterious Palladin Mutations in Patients with Familial Pancreatic Cancer
Klein, A. P., Borges, M. W., Griffith, M., Brune, K. A., Hong, S., Omura, N., Hruban, R. H., & Goggins, M. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0056 · Cited by 44
Self-citationFamilial Pancreatic Cancer and the Genetics of Pancreatic Cancer
Lumadue, J. A., Griffin, C. A., Hruban, R. H., & Osman, M. (1995) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)46731-9 · Cited by 37
Self-citationKluijt, I., Cats, A., Fockens, P., Nio, C. Y., Gouma, D. J., & Bruno, M. J. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181981123 · Cited by 31
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer–prone families
Lynch, H. T., Brand, R. E., Lynch, J. F., Fusaro, R. M., Smyrk, T. C., Goggins, M., & Kern, S. E. (2000) · Gastroenterology · doi:10.1053/gast.2000.20335 · Cited by 30
Self-citationA new indication for pancreas transplantation: high grade pancreatic dysplasia
Charpentier, K. P., Brentnall, T. A., Bronner, M. P., Byrd, D. R., & Marsh, C. L. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00110.x · Cited by 27
Patient Perspective on the Value of Genetic Counselling for Familial Pancreas Cancer
Axilbund, J. E., Brune, K. A., Canto, M. I., Brehon, B., Wroblewski, L. D., & Griffin, C. A. (2005) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-3-3-115 · Cited by 25
Self-citationPancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
Cappel, W. H. D. V. T. N., Offerhaus, G. J. A., van Puijenbroek, M., Caspers, E., Gruis, N. A., de Snoo, F. A., Lamers, C. B. H. W., Griffioen, G. G., Bergman, W., Vasen, H. F. A., et al. (2003) · PubMed · Cited by 23
Aimoto, T., Uchida, E., Nakamura, Y., Matsushita, A., Katsuno, A., Chou, K., Kawamoto, M., Naito, Z., & Tajiri, T. (2008) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-007-1269-7 · Cited by 22
Skin self-examination of persons from families with familial atypical multiple mole melanoma (FAMMM)
Mesters, I., Jonkman, L., Vasen, H. F. A., et al. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.09.017 · Cited by 14
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1004(1998)12:1 · Cited by 1
Cited by
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4846 · Cited by 1,908
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M., Behrman, S. W., Benson, A. B., Cardin, D. B., Chiorean, E. G., Chung, V., Czito, B., Del Chiaro, M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0017 · Cited by 1,304
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
“57 However, follow-up imaging was recommended less than 6 months after surgery if there was any PanIN-3 in the resected pancreas of individuals without PC.”
BackgroundInfluentialSelf-citationOhtsuka, T., Fernandez-del Castillo, C., Furukawa, T., Hijioka, S., Jang, J.-Y., Lennon, A. M., Miyasaka, Y., Ohno, E., Salvia, R., Wolfgang, C. L., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2023.12.009 · Cited by 510
Metadata
- Authors
- Hruban, R. H., Canto, M. I., Goggins, M., Schulick, R., & Klein, A. P.
- Venue
- Advances in Surgery
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 44
- Issue
- 1
- Pages
- 293-311
- ISSN
- 0065-3411 (ISSN-L)
- OpenAlex
- W2111898090
- Cited by
- 268
- References
- 103
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.